Medicamen Biotech standalone net profit rises 228.57% in the September 2016 quarter
Sales rise 27.65% to Rs 22.90 crore
Net profit of Medicamen Biotech rose 228.57% to Rs 1.15 crore in the quarter ended September 2016 as against Rs 0.35 crore during the previous quarter ended September 2015. Sales rose 27.65% to Rs 22.90 crore in the quarter ended September 2016 as against Rs 17.94 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales22.9017.94 28 OPM %11.886.80 -PBDT1.920.79 143 PBT1.450.32 353 NP1.150.35 229Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content